'High-alert' medications and patient safety.
D000925:Anticoagulants / Q000009:adverse effects; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D007328:Insulin / Q000009:adverse effects; D007591:Joint Commission on Accreditation of Healthcare Organizations; D008508:Medication Errors / Q000517:prevention & control*; D008510:Medication Systems, Hospital / Q000592:standards*; D009294:Narcotics / Q000009:adverse effects; D011188:Potassium / Q000009:adverse effects; D017751:Safety Management; D018571:Sentinel Surveillance; D012965:Sodium Chloride / Q000009:adverse effects; D014481:United States
D000925:Anticoagulants; D007328:Insulin; D009294:Narcotics; D012965:Sodium Chloride; D006493:Heparin; D011188:Potassium